Oelze M, Daiber A, Brandes RP, others, et al
The current evidence on semaglutide (Ozempic, Ryblesus, Wegovy), liraglutide (Saxenda, Victoza, Xultophy), and dulaglutide (Trulicity) does not show a similar effect
Watching them fall into the optimal zone for health can be one of the most rewarding parts of treatment
Keep a mixing log
doi: 10.1038/s41467-022-28683-0 127 KnerrPJMowerySADourosJDPremdjeeBHjllundKRHeYet al
Comparative efficacy of 5 sodium glucose cotransporter 2 inhibitor and 7 glucagon-like peptide 1 receptor agonists interventions on cardiorenal outcomes in type 2 diabetes patients: a network meta-analysis based on cardiovascular or renal outcome trials